ContextVision AB (publ) (OSL: CONTX)

Norway flag Norway · Delayed Price · Currency is NOK
5.38
+0.10 (1.89%)
Jan 17, 2025, 4:25 PM CET
-32.75%
Market Cap 413.14M
Revenue (ttm) 140.63M
Net Income (ttm) 22.57M
Shares Out 77.37M
EPS (ttm) 0.29
PE Ratio 18.51
Forward PE 18.57
Dividend n/a
Ex-Dividend Date n/a
Volume 42,913
Average Volume 115,143
Open 5.28
Previous Close 5.28
Day's Range 5.20 - 5.38
52-Week Range 4.52 - 9.20
Beta 1.06
RSI 45.56
Earnings Date Feb 2, 2025

About ContextVision AB

ContextVision AB (publ), a medical technology software company, provides image analysis and imaging for medical systems in Asia, Europe, and America. The company offers image enhancement software for 2D/3D/4D ultrasound, radiography, magnetic resonance imaging (MRI), and veterinary uses. Its products include Rivent that offers image enhancement and visualization solutions for ultrasound systems for women’s health, general imaging, cardiovascular, and point of care applications; Rivent Mobile, a 2D image enhancement product for handheld units; a... [Read more]

Sector Healthcare
Founded 1983
Employees 40
Stock Exchange Oslo Børs
Ticker Symbol CONTX
Full Company Profile

Financial Performance

In 2023, ContextVision AB's revenue was 132.60 million, an increase of 7.62% compared to the previous year's 123.21 million. Earnings were 32.73 million, an increase of 13.68%.

Financial numbers in SEK Financial Statements

News

There is no news available yet.